X4 Pharmaceuticals Files 8-K on Operations
Ticker: XFOR · Form: 8-K · Filed: Mar 25, 2025 · CIK: 1501697
| Field | Detail |
|---|---|
| Company | X4 Pharmaceuticals, Inc (XFOR) |
| Form Type | 8-K |
| Filed Date | Mar 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: operations, financial-condition
TL;DR
X4 Pharma filed an 8-K on 3/25/25 detailing its financial and operational status.
AI Summary
X4 Pharmaceuticals, Inc. filed an 8-K on March 25, 2025, reporting on its financial condition and operations. The company, formerly known as Arsanis, Inc., is based in Boston, MA, and operates in the biological products sector.
Why It Matters
This filing provides an update on X4 Pharmaceuticals' financial condition and operational status, which is crucial for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — This is a routine filing providing standard corporate information and does not indicate any immediate or significant risks.
Key Players & Entities
- X4 Pharmaceuticals, Inc. (company) — Registrant
- Arsanis, Inc. (company) — Former company name
- March 25, 2025 (date) — Date of report
- Boston, Massachusetts (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing for X4 Pharmaceuticals, Inc.?
The 8-K filing serves as a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, detailing the company's results of operations and financial condition.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on March 25, 2025.
What was X4 Pharmaceuticals, Inc. formerly known as?
X4 Pharmaceuticals, Inc. was formerly known as Arsanis, Inc.
Where are X4 Pharmaceuticals, Inc.'s principal executive offices located?
The principal executive offices of X4 Pharmaceuticals, Inc. are located at 61 North Beacon Street, 4th Floor, Boston, Massachusetts 02134.
What is the Standard Industrial Classification code for X4 Pharmaceuticals, Inc.?
The Standard Industrial Classification code for X4 Pharmaceuticals, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 25, 2025 regarding X4 Pharmaceuticals, Inc (XFOR).